Usefulness of JAK2V617F mutation in distinguishing idiopathic erythrocytosis from polycythemia vera

Davide Rossi, Francesca Cortini, Clara Deambrogi, Caterina Barbieri, Michaela Cerri, Silvia Franceschetti, Annarita Conconi, Daniela Capello, Gianluca Gaidano

Research output: Contribution to journalArticlepeer-review

Abstract

Idiopathic erythrocytosis (IE) is a primary erythrocytosis not fulfilling the criteria for polycythemia vera (PV) diagnosis. In order to verify the relationship between IE and PV, we screened JAK2V617F mutation in a consecutive series of 11 IE and, for comparison, in 15 PV. JAK2V617F mutation was screened by both cDNA sequencing and mutation specific PCR in both peripheral blood and bone marrow samples. All 11 IE tested negative for JAK2V617F mutation, which, conversely, occurred in 11/15 (73.3%) PV. Our results demonstrate that JAK2V617F is absent in IE and may represent a useful molecular marker for distinguishing IE from PV.

Original languageEnglish
Pages (from-to)97-101
Number of pages5
JournalLeukemia Research
Volume31
Issue number1
DOIs
Publication statusPublished - Jan 2007

Keywords

  • Chronic myeloproliferative disorders
  • Idiopathic erythrocytosis
  • JAK2
  • Polycythemia vera
  • Primary erythrocytosis

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Usefulness of JAK2V617F mutation in distinguishing idiopathic erythrocytosis from polycythemia vera'. Together they form a unique fingerprint.

Cite this